Is obstructive sleep apnoea a comorbidity of COPD and is it involved in chronic systemic inflammatory syndrome? Source: Eur Respir J 2008; 31: 1381-1382 Year: 2008
The prevalance of cardiovascular disorders in patients with obstructive sleep apnoea syndrome Source: Eur Respir J 2002; 20: Suppl. 38, 293s Year: 2002
Early signs of cardiovascular system dysfunction in obstructive sleep apnea (OSA) patients before clinical manifestation Source: Annual Congress 2009 - Cardiovascular complications in obstructive sleep apnoea Year: 2009
Obstructive sleep apnea syndrome and cardiovascular diseases risk in patients with COPD Source: Annual Congress 2012 - Physiology, heart failure and respiration in relation to OSA Year: 2012
Incidence of cardiovascular complications in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders Year: 2007
The evaluation of risk of obstructive sleep apnea syndrome in individuals with dysglycaemia Source: Annual Congress 2012 - Clinical predictors of OSA, adherence to CPAP and psychology Year: 2012
Cardiovascular risk factors and the metabolic syndrome in patients with obstructive sleep apnea Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea Year: 2008
The risk of future cardiovascular diseases in the patients with OSAS is dependently or independently associated with obstructive sleep apnoea Source: Eur Respir J 2001; 17: 573-574 Year: 2001
The role of inflammatory biomarkers in obstructive sleep apnea syndrome Source: International Congress 2018 – Sleep-disordered breathing: biomarkers and genetics and the role of hypoxia, insomnia, movement disorders and sleep quality Year: 2018
Prevalence of co-morbidities and clinical features in patients with obstructive sleep apnea and chronic obstructive pulmonary disease. Source: International Congress 2018 – From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS) Year: 2018
Obstructive pulmonary disorder is a potential risk factor of cardiovascular diseases in obstructive sleep apnea Source: Annual Congress 2008 - Control of breathing and respiratory disorders during sleep Year: 2008
Treatment control in risk patients with obstructive sleep apnea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 411s Year: 2006
The impact of obstructive sleep apnoea syndrome on endothelial function in patients with moderate and severe hypertension Source: Eur Respir J 2005; 26: Suppl. 49, 39s Year: 2005
Autoantibody against NBL1 in obstructive sleep apnea patients with cardiovascular disease Source: International Congress 2017 – New insights into the understanding of sleep and the consequences of sleep apnoea Year: 2017
Prevalence of metabolic syndrome in patients with hypertension and obstructive sleep apnea Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea Year: 2009
Unrecognised systemic hypertension in patients with obstructive sleep apnoea Source: Eur Respir J 2006; 28: Suppl. 50, 643s Year: 2006
Prevalence of very severe obstructive sleep apnea syndrome from symptomatic patients. Source: International Congress 2019 – Screening tools, prevalence and predictors of obstructive sleep apnoea Year: 2019
The impact of obstructive sleep apnea syndrome on cardiovascular system in children Source: Annual Congress 2011 - Obstructive sleep apnoea: the heart and the brain Year: 2011
The difference in obstructive sleep apnoea symptoms between patients with obstructive and inflammatory diseases Source: Eur Respir J 2005; 26: Suppl. 49, 65s Year: 2005
Impaired glucose tolerance and other cardiovascular risk factors in patients with obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing Year: 2009